Meet Yale Internal Medicine: Vivian Asare, MD, Assistant Professor of Medicine (Pulmonary, Critical Care, and Sleep Medicine).
As part of our “Meet Yale Internal Medicine” series, today’s featured physician is Vivian Asare, MD, assistant professor of medicine (pulmonary, critical care, and sleep medicine).
With Cellular Blueprint for Lungs, Yale Researchers Look Ahead to Organ Regeneration
Using sophisticated screening across animal species, researchers at Yale have created a cellular blueprint of the human lung that will make it easier to understand the design principles behind lung function and disease — and to bioengineer new lungs. The research, published Dec. 4 in Science Advances, represents a collaboration between two Yale labs — that of Naftali Kaminski, M.D., chief of pulmonary, critical care, and sleep medicine at Yale School of Medicine, and Laura Niklason, M.D., Ph.D., the Nicholas Greene Professor of anesthesiology and biomedical engineering and an expert in stimulating growth of new lung tissue from the body’s own cells for use in transplants.
Yale Study Provides Insights Into How Fibrosis Progresses in the Human Lung
A Yale-led collaborative study boosts scientific understanding of how the lung disease idiopathic pulmonary fibrosis (IPF) progresses, providing a roadmap for researchers to discover new treatment targets for the disease.
Moving Toward Family-friendly Intensive Care Units
As with other forms of health care, there is increasing desire by patients and their loved ones to be more involved in what happens in hospital intensive care units (ICUs). But it is possible this desire can clash with pressures that are inherent in caring for patients whose health is so precarious, and ingrained routines that ICU staff often embrace. Yale clinicians, in a study published in Critical Care Medicine, collaborated with the Society of Critical Care Medicine (SCCM) to demonstrate potential routes for making intensive care more patient- and family-centered.
Respiratory Experts Fight for Climate Change Measures
In the paper “Climate change and lung health – presidential failure, professional responsibility,” respiratory experts are again voicing their concern regarding the environmental policies of President Donald Trump and its connection to lung health.
New test could lead to personalized treatments for cystic fibrosis
Cystic fibrosis is a devastating disease caused by mutations in a specific gene, known as the CFTR gene. But not everyone with cystic fibrosis has the same symptoms or responds to drug treatments in the same way. In a new pilot study, researchers from the University of Cambridge and Yale University developed a novel, straightforward way to test multiple drugs on cells obtained from individual patients with cystic fibrosis, raising the possibility of highly personalized drug treatment.
New Treatment to Remove Clots Offers Dramatic Results
A new interventional radiology procedure to treat blood clots does not require the use of thrombolytic agents – clot-busting medicines that can result in bleeding elsewhere in the body. This expands the ability to treat older patients, or patients with other medical issues who are at a higher risk for bleeding.
Fighting the Cold Virus and Other Threats, Body Makes Trade-off, Says Study
A Yale research team has revealed how cells in different parts of the human airway vary in their response to the common cold virus. Their finding, published in Cell Reports, could help solve the mystery of why some people exposed to the cold virus get ill while others don’t, said the researchers.
Proposed legislation would subject e-cigarettes to age verification law
New legislation proposed June 5 by Congresswoman Rosa DeLauro, D-Conn., would require Internet and mail order sellers of electronic cigarettes to verify a person’s age and identity before they deliver their products to a buyer’s door.
Crosstalk between cells plays role in pulmonary hypertension
Pulmonary hypertension is a type of high blood pressure that affects blood vessels in the lungs. Once diagnosed, patients have limited treatment options, and many do not live beyond seven years. In a new study, scientists in the Yale Cardiovascular Research Center have gained new insight into the development of the disease that could lead to new therapies.
New Research Opens Door for Potential Treatment of Deadly Lung Disease
Chronic Obstructive Pulmonary Disease (COPD) is the fourth leading cause of death globally Every year, over 12 million U.S. adults are diagnosed with COPD, and 120,000 die from it. For people with the disease, the bacterium Haemophilus influenzae is particularly dangerous.
Early Screening for Lung Cancer? Many people are not aware you can be tested for the disease
Lung cancer is the second most common cancer in both men and women, and is by far the leading cause of cancer death. In 2017, the American Cancer Society estimates more than 200,000 new cases of lung cancer will be diagnosed in the United States, with more than 150,000 deaths. Lung cancer screening is now approved in the United States, and can help detect cancer early, when it is most curable. With November Lung Cancer Awareness Month, Lynn Tanoue, MD and Polly Sather, MSN, APRN, from the Lung Screening and Nodule Program at Yale Cancer Center, talk about lung cancer screening and why it can save lives.